ACST

Acasti Pharma, Inc. - Class A

SCoRE: 58

LAST PRICE - AT THE CLOSE

ACST is UP 5% since the begininning of the year

ACST is DOWN -3% BELOW 20 day SMA

ACST is UP 16% ABOVE 200 day SMA

View More ACST Price Action

PROFITABLE: NO
EPS: $-0.21

EARNINGS MOMENTUM: YES
0.4% INCREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00

REVENUE IS: N/A

DEBT IS: 24

CASH IS: 25M

	THE STOCK IS 99.5% AWAY FROM ALL-TIME HIGHS OF $585.6
	ACST IS UP 5% SINCE THE BEGINNING OF THE YEAR
	ACST IS UP 17% OVER THE PAST 12 MONTHS
	ACST IS DOWN -10% OVER THE PAST 1 MONTH
	0% OF ALL ACST INVESTORS ARE BETTING AGAINST ACST
	NUM INVESTORS SHORT ACST HAS GONE UP N/A% VERSUS LAST MONTH